Miyamoto Toshihiro, Iwasaki Hiromi, Reizis Boris, Ye Min, Graf Thomas, Weissman Irving L, Akashi Koichi
Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Palo Alto, CA 94305, USA.
Dev Cell. 2002 Jul;3(1):137-47. doi: 10.1016/s1534-5807(02)00201-0.
We demonstrate here that "promiscuous" expression of myeloid or lymphoid genes precedes lineage commitment in hematopoiesis. Prospectively purified single common myeloid progenitors (CMPs) coexpress myelo-erythroid but not lymphoid genes, whereas single common lymphoid progenitors (CLPs) coexpress T and B lymphoid but not myeloid genes. Genes unrelated to the adopted lineage are downregulated in bipotent and monopotent descendants of CMPs and CLPs. Promiscuous gene expression does not alter the biological potential of multipotent progenitors: CMPs with an activated endogenous M lysozyme locus yield normal proportions of myelo-erythroid colonies, and CLPs expressing the pre-T cell receptor alpha gene differentiate into normal numbers of B cells. Thus, the accessibility for multiple myeloid or lymphoid programs promiscuously may allow flexibility in fate commitments at these multipotent stages.
我们在此证明,在造血过程中,髓系或淋巴系基因的“混杂”表达先于谱系定向。前瞻性纯化的单个共同髓系祖细胞(CMP)共表达髓系-红系基因,但不表达淋巴系基因,而单个共同淋巴系祖细胞(CLP)共表达T和B淋巴系基因,但不表达髓系基因。与所采用谱系无关的基因在CMP和CLP的双能和单能后代中下调。混杂的基因表达不会改变多能祖细胞的生物学潜能:具有激活的内源性M溶菌酶基因座的CMP产生正常比例的髓系-红系集落,表达前T细胞受体α基因的CLP分化为正常数量的B细胞。因此,多个髓系或淋巴系程序的混杂可及性可能允许在这些多能阶段的命运决定具有灵活性。